Asunto(s)
Antígenos de Superficie de la Hepatitis B/sangre , Vacunas contra Hepatitis B/inmunología , Precursores de Proteínas/sangre , Vacunas Sintéticas/inmunología , Vacunas contra Hepatitis B/administración & dosificación , Humanos , India , Resultado del Tratamiento , Vacunas Sintéticas/administración & dosificaciónRESUMEN
Serum angiotensin converting enzyme (SACE) was estimated in 18 cases of sarcoidosis, 15 patients suffering from pulmonary tuberculosis and in 12 normal healthy individuals. SACE was elevated in the patients suffering from sarcoidosis. (33.2 +/- 12.9). SACE values for the pulmonary tuberculosis patients were 18.8 +/- 7.9 and those for the normal healthy individuals were 17.1 +/- 4.7. Compared to pulmonary tuberculosis and normal healthy individuals, the SACE levels were significantly elevated (P < 0.01) in sarcoidosis patients.
Asunto(s)
Enfermedades Pulmonares/enzimología , Peptidil-Dipeptidasa A/sangre , Sarcoidosis/enzimología , Tuberculosis Pulmonar/enzimología , Humanos , Enfermedades Pulmonares/sangre , Sarcoidosis/sangre , Espectrofotometría , Tuberculosis Resistente a Múltiples Medicamentos/sangre , Tuberculosis Resistente a Múltiples Medicamentos/enzimología , Tuberculosis Pulmonar/sangreRESUMEN
HLA typing was performed on 18 patients suffering from sarcoidosis and 30 patients suffering from diffuse interstitial pulmonary fibrosis. One hundred normal healthy people ethnically matched served as the controls. On statistical analysis, the corrected 'p' value of all the HLA antigens for both the patient groups was non significant. The results therefore suggest that there is no particular HLA antigen associated with sarcoidosis and diffuse interstitial pulmonary fibrosis.
Asunto(s)
Antígenos HLA/análisis , Enfermedades Pulmonares/inmunología , Fibrosis Pulmonar/inmunología , Sarcoidosis/inmunología , Estudios de Casos y Controles , Etnicidad , Antígenos HLA-A/análisis , Antígenos HLA-B/análisis , Antígeno HLA-B39 , Antígenos HLA-C/análisis , Antígenos HLA-DR/análisis , HumanosRESUMEN
Twenty-five resident doctors were given 1 ml (20 micrograms) of recombinant hepatitis B vaccine intramuscularly in the deltoid region at 0, 1 and 6 months. Seroconversion rates at 1, 2, 3, 7 and 8 months were 8%, 48%, 64%, 96% and 100% respectively. Acceptability of the vaccine was 100%. The recombinant hepatitis B vaccine is safe and efficacious, with seroconversion rates comparable to the plasma derived vaccine, and has negligible side effects.
Asunto(s)
Hepatitis B/prevención & control , Enfermedades Profesionales/prevención & control , Médicos , Vacunas contra Hepatitis Viral , Adulto , Femenino , Vacunas contra Hepatitis B , Humanos , Masculino , Proteínas Recombinantes , Factores de Tiempo , VacunaciónAsunto(s)
Antígenos HLA , Antígenos HLA-B , Esclerosis Múltiple/inmunología , Etnicidad , Humanos , IndiaRESUMEN
The infrequency of multiple sclerosis in India may have genetic implications. We found (a) the HLA-A3 and HLA-B7 haplotypes amongst Indians to be lower than those reported in Caucasians, (b) no excess of HLA-A3 and HLA-B7 amongst our 27 multiple sclerosis patients compared to 330 controls; instead it was the reverse, (c) HLA-B12 as high as 74% in the "clinically definite" cases, against only 9% in controls, (d) a significant relative risk of MS amongst Indians with HLA-B12 haplotype. Attention is drawn to th higher incidence of MS amongst the small Parsee community and the high association of HLA-B12 in these patients.
Asunto(s)
Antígenos HLA/análisis , Esclerosis Múltiple/inmunología , Población Blanca , Humanos , India , Esclerosis Múltiple/genéticaRESUMEN
In Indian patients with Multiple Sclerosis it was observed, upon testing for serum determinable histocompatibility antigens, that HLA-B12 antigen was present in excess (77.7%), in comparison with normal controls (13.8%). In fact, in the sub-group of 'clinically definite' patients, the B12 antigen excess was remarkable (84%). These preliminary findings seem to point to a different immunogenetic profile of Indian MS patients in comparison with Western and Japanese series. Relevant published information relating to the HLA-B12 alleles in disease processes is discussed in order to provide a basis for further work.